Synergic treatment of Alzheimer’s disease with brain targeted nanoparticles incorporating NgR-siRNA and brain derived neurotrophic factor-Reference-Cited by-同舟云学术

Synergic treatment of Alzheimer’s disease with brain targeted nanoparticles incorporating NgR-siRNA and brain derived neurotrophic factor

Published:2020 Issue: Volume:1 Page:125-130
ISSN:2590-1834
Container-title:Smart Materials in Medicine
language:en
Short-container-title:Smart Materials in Medicine

Author:

Wang Zhanwen,Cheng Ying,Zhao Deqiang,Pliss Artem,Liu Jun,Luan Ping^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Biomedical Engineering,Biomaterials,Bioengineering

Reference27 articles.

1. The epigenome in Alzheimer’s disease: current state and approaches for a new path to gene discovery and understanding disease mechanism;Klein;Acta Neuropathol.,2016

2. Meta-analysis of the relationship of peripheral retinal nerve fiber layer thickness to Alzheimer’s disease and mild cognitive impairment;Wang;Shanghai Arch Psychiatry,2015

3. Brain-derived neurotrophic factor gene-modified bone marrow mesenchymal stem cells;Han;Exp Ther Med,2015

4. Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity;Akbik;Exp. Neurol.,2012

5. Novel concept of the smart NIR-light-controlled drug release of black phosphorus nanostructure for cancer therapy;Qiu;Proc. Natl. Acad. Sci. U. S. A.,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging paradigms in Alzheimer's therapy;European Journal of Pharmacology;2024-10

2. Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease;European Journal of Neuroscience;2024-04-15

3. Advances in Nanotechnology for Drug Delivery Modulation in Neurodegenerative Diseases;Handbook of Neurodegenerative Disorders;2023-11-28

4. Alzheimer's Disease: Status of Low‐Dimensional Nanotherapeutic Materials;Advanced Functional Materials;2023-10-06

5. siRNA drug delivery across the blood–brain barrier in Alzheimer's disease;Advanced Drug Delivery Reviews;2023-08